Annual Total Expenses
$13.58 M
-$7.68 M-36.13%
31 December 2023
Summary:
GT Biopharma annual total expenses is currently $13.58 million, with the most recent change of -$7.68 million (-36.13%) on 31 December 2023. During the last 3 years, it has risen by +$6.81 million (+100.71%). GTBP annual total expenses is now -89.99% below its all-time high of $135.57 million, reached on 31 December 2017.GTBP Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$3.60 M
-$302.00 K-7.73%
30 September 2024
Summary:
GT Biopharma quarterly total expenses is currently $3.60 million, with the most recent change of -$302.00 thousand (-7.73%) on 30 September 2024. Over the past year, it has increased by +$482.00 thousand (+15.44%). GTBP quarterly total expenses is now -97.16% below its all-time high of $126.86 million, reached on 30 September 2017.GTBP Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTBP Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.1% | +15.4% |
| 3 y3 years | +100.7% | -39.5% |
| 5 y5 years | -37.0% | -15.3% |
GTBP Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.4% | +100.7% | -80.2% | +19.6% |
| 5 y | 5 years | -76.4% | +100.7% | -87.6% | +316.2% |
| alltime | all time | -90.0% | +1069.3% | -97.2% | +4042.5% |
GT Biopharma Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.60 M(-7.7%) |
| June 2024 | - | $3.91 M(+26.4%) |
| Mar 2024 | - | $3.09 M(-2.4%) |
| Dec 2023 | $13.58 M(-36.1%) | $3.17 M(+1.5%) |
| Sept 2023 | - | $3.12 M(-13.8%) |
| June 2023 | - | $3.62 M(-1.2%) |
| Mar 2023 | - | $3.67 M(-36.6%) |
| Dec 2022 | $21.26 M(-63.0%) | $5.78 M(-17.7%) |
| Sept 2022 | - | $7.02 M(+133.0%) |
| June 2022 | - | $3.01 M(-44.6%) |
| Mar 2022 | - | $5.44 M(-70.1%) |
| Dec 2021 | $57.52 M(+750.3%) | $18.18 M(+205.3%) |
| Sept 2021 | - | $5.95 M(+35.9%) |
| June 2021 | - | $4.38 M(-84.9%) |
| Mar 2021 | - | $29.00 M(+1223.7%) |
| Dec 2020 | $6.76 M(-41.0%) | $2.19 M(+12.6%) |
| Sept 2020 | - | $1.95 M(+24.8%) |
| June 2020 | - | $1.56 M(+45.6%) |
| Mar 2020 | - | $1.07 M(+23.6%) |
| Dec 2019 | $11.46 M(-46.8%) | $866.00 K(-79.7%) |
| Sept 2019 | - | $4.26 M(+86.7%) |
| June 2019 | - | $2.28 M(-43.8%) |
| Mar 2019 | - | $4.06 M(+31.2%) |
| Dec 2018 | $21.55 M(-84.1%) | $3.09 M(-49.7%) |
| Sept 2018 | - | $6.15 M(+19.2%) |
| June 2018 | - | $5.16 M(-28.0%) |
| Mar 2018 | - | $7.16 M(+21.5%) |
| Dec 2017 | $135.57 M(+1346.2%) | $5.89 M(-95.4%) |
| Sept 2017 | - | $126.86 M(+9772.1%) |
| June 2017 | - | $1.28 M(-16.4%) |
| Mar 2017 | - | $1.54 M(+87.1%) |
| Dec 2016 | $9.37 M(+4.7%) | $822.00 K(-67.5%) |
| Sept 2016 | - | $2.53 M(+19.3%) |
| June 2016 | - | $2.12 M(-45.6%) |
| Mar 2016 | - | $3.90 M(+34.1%) |
| Dec 2015 | $8.95 M(+264.4%) | $2.91 M(+4.7%) |
| Sept 2015 | - | $2.78 M(+91.4%) |
| June 2015 | - | $1.45 M(-20.2%) |
| Mar 2015 | - | $1.82 M(+8.5%) |
| Dec 2014 | $2.46 M(+111.6%) | $1.68 M(+203.4%) |
| Sept 2014 | - | $552.00 K(+327.9%) |
| June 2014 | - | $129.00 K(+27.7%) |
| Mar 2014 | - | $101.00 K(-63.0%) |
| Dec 2013 | $1.16 M(-69.9%) | $273.00 K(-15.5%) |
| Sept 2013 | - | $323.00 K(+148.5%) |
| June 2013 | - | $130.00 K(-70.1%) |
| Mar 2013 | - | $435.00 K(-54.6%) |
| Dec 2012 | $3.86 M(-2.5%) | $958.00 K(-34.8%) |
| Sept 2012 | - | $1.47 M(+42.6%) |
| June 2012 | - | $1.03 M(+159.0%) |
| Mar 2012 | - | $398.00 K(-62.1%) |
| Dec 2011 | $3.95 M(+57.7%) | $1.05 M(+93.6%) |
| Sept 2011 | - | $543.00 K(+12.7%) |
| June 2011 | - | $482.00 K(-74.3%) |
| Mar 2011 | - | $1.88 M(+249.1%) |
| Dec 2010 | $2.51 M(+108.3%) | $538.00 K(-17.7%) |
| Sept 2010 | - | $654.00 K(+69.4%) |
| June 2010 | - | $386.00 K(-58.5%) |
| Mar 2010 | - | $930.00 K(+27.9%) |
| Dec 2009 | $1.20 M(-48.9%) | $727.00 K(+735.6%) |
| Sept 2009 | - | $87.00 K(-65.3%) |
| June 2009 | - | $251.00 K(+80.6%) |
| Mar 2009 | - | $139.00 K(-64.8%) |
| Dec 2008 | $2.35 M(-67.1%) | $395.00 K(-46.7%) |
| Sept 2008 | - | $741.00 K(+73.1%) |
| June 2008 | - | $428.00 K(-45.8%) |
| Mar 2008 | - | $789.00 K(-63.5%) |
| Dec 2007 | $7.17 M | $2.16 M(+23.5%) |
| Sept 2007 | - | $1.75 M(+24.4%) |
| June 2007 | - | $1.41 M(-23.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | $1.84 M(-29.7%) |
| Dec 2006 | $8.45 M(+101.8%) | $2.62 M(+39.0%) |
| Sept 2006 | - | $1.89 M(+2.0%) |
| June 2006 | - | $1.85 M(-11.7%) |
| Mar 2006 | - | $2.09 M(+36.1%) |
| Dec 2005 | $4.19 M(+18.9%) | $1.54 M(+76.4%) |
| Sept 2005 | - | $872.00 K(-2.2%) |
| June 2005 | - | $892.00 K(+0.9%) |
| Mar 2005 | - | $884.00 K(+271.4%) |
| Dec 2004 | $3.52 M(+0.2%) | $238.00 K(-70.6%) |
| Sept 2004 | - | $810.00 K(-13.5%) |
| June 2004 | - | $936.00 K(-7.4%) |
| Mar 2004 | - | $1.01 M(-13.9%) |
| Dec 2003 | $3.51 M(+22.8%) | $1.17 M(+67.7%) |
| Sept 2003 | - | $700.00 K(-25.2%) |
| June 2003 | - | $936.00 K(+33.1%) |
| Mar 2003 | - | $703.00 K(+22.0%) |
| Dec 2002 | $2.86 M(-55.4%) | $576.00 K(-20.2%) |
| Sept 2002 | - | $722.00 K(-17.8%) |
| June 2002 | - | $878.00 K(+28.2%) |
| Mar 2002 | - | $685.00 K(+0.7%) |
| Dec 2001 | $6.42 M(-22.3%) | $680.00 K(-32.4%) |
| Sept 2001 | - | $1.01 M(-61.2%) |
| June 2001 | - | $2.60 M(+21.8%) |
| Mar 2001 | - | $2.13 M(-4.6%) |
| Dec 2000 | $8.27 M(-28.6%) | $2.23 M(+1.6%) |
| Sept 2000 | - | $2.20 M(+14.4%) |
| June 2000 | - | $1.92 M(+0.5%) |
| Mar 2000 | - | $1.91 M(-25.7%) |
| Dec 1999 | $11.57 M(-5.1%) | $2.58 M(+35.5%) |
| Sept 1999 | - | $1.90 M(-57.8%) |
| June 1999 | - | $4.50 M(+66.7%) |
| Mar 1999 | - | $2.70 M(-20.6%) |
| Dec 1998 | $12.20 M(+20.8%) | $3.40 M(+6.3%) |
| Sept 1998 | - | $3.20 M(+18.5%) |
| June 1998 | - | $2.70 M(-15.6%) |
| Mar 1998 | - | $3.20 M(+14.3%) |
| Dec 1997 | $10.10 M(-5.6%) | $2.80 M(0.0%) |
| Sept 1997 | - | $2.80 M(+33.3%) |
| June 1997 | - | $2.10 M(-16.0%) |
| Mar 1997 | - | $2.50 M(+4.2%) |
| Dec 1996 | $10.70 M(+0.9%) | $2.40 M(-17.2%) |
| Sept 1996 | - | $2.90 M(+3.6%) |
| June 1996 | - | $2.80 M(0.0%) |
| Mar 1996 | - | $2.80 M(+3.7%) |
| Dec 1995 | $10.60 M(+92.7%) | $2.70 M(+8.0%) |
| Sept 1995 | - | $2.50 M(0.0%) |
| June 1995 | - | $2.50 M(-13.8%) |
| Mar 1995 | - | $2.90 M(+11.5%) |
| Dec 1994 | $5.50 M(+17.0%) | $2.60 M(+116.7%) |
| Sept 1994 | - | $1.20 M(+100.0%) |
| June 1994 | - | $600.00 K(-45.5%) |
| Mar 1994 | - | $1.10 M(+37.5%) |
| Dec 1993 | $4.70 M(+42.4%) | $800.00 K(-46.7%) |
| Sept 1993 | - | $1.50 M(-21.1%) |
| June 1993 | - | $1.90 M(+280.0%) |
| Mar 1993 | - | $500.00 K(-28.6%) |
| Dec 1992 | $3.30 M(+3.1%) | $700.00 K(-36.4%) |
| Sept 1992 | - | $1.10 M(+22.2%) |
| June 1992 | - | $900.00 K(+80.0%) |
| Mar 1992 | - | $500.00 K(-16.7%) |
| Dec 1991 | $3.20 M(-25.6%) | $600.00 K(-45.5%) |
| Sept 1991 | - | $1.10 M |
| Dec 1990 | $4.30 M(-6.5%) | - |
| Dec 1989 | $4.60 M(+39.4%) | - |
| Dec 1988 | $3.30 M(+57.1%) | - |
| Dec 1987 | $2.10 M(-41.7%) | - |
| Dec 1986 | $3.60 M(+12.5%) | - |
| Dec 1985 | $3.20 M(-31.9%) | - |
| Dec 1984 | $4.70 M(-4.1%) | - |
| Feb 1984 | $4.90 M | - |
FAQ
- What is GT Biopharma annual total expenses?
- What is the all time high annual total expenses for GT Biopharma?
- What is GT Biopharma annual total expenses year-on-year change?
- What is GT Biopharma quarterly total expenses?
- What is the all time high quarterly total expenses for GT Biopharma?
- What is GT Biopharma quarterly total expenses year-on-year change?
What is GT Biopharma annual total expenses?
The current annual total expenses of GTBP is $13.58 M
What is the all time high annual total expenses for GT Biopharma?
GT Biopharma all-time high annual total expenses is $135.57 M
What is GT Biopharma annual total expenses year-on-year change?
Over the past year, GTBP annual total expenses has changed by -$7.68 M (-36.13%)
What is GT Biopharma quarterly total expenses?
The current quarterly total expenses of GTBP is $3.60 M
What is the all time high quarterly total expenses for GT Biopharma?
GT Biopharma all-time high quarterly total expenses is $126.86 M
What is GT Biopharma quarterly total expenses year-on-year change?
Over the past year, GTBP quarterly total expenses has changed by +$482.00 K (+15.44%)